Clinical Trial Update: Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01) [Phase 2]

View source ↗

Summary

Phase 2 extension study update for PTR-01-002 in patients with recessive dystrophic epidermolysis bullosa (RDEB) who were previously treated with PTR-01; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• PTR-01

Snippet

Sponsor: Phoenix Tissue Repair, Inc. | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 2 | Status: COMPLETED